Influenza is affecting hundreds of thousands of people in Japan and rising rapidly among that nation's population of 124.5 ...

A new review of data for Roche's flu drug Tamiflu has concluded the drug does not reduce hospitalisations and serious complications of the virus – and that it leads to harmful effects in patients.

By bno - Tokyo bureau Japan has seen a dramatic spike in flu cases, reaching the highest levels since record-keeping began in ...

Not a substitute for annual influenza vaccination. Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use. Not recommended for ...

The number of influenza patients reported at designated medical institutions across Japan at the end of the year hit the ...

Engineering microbes could be our best hope for creating enough antiviral drugs. As fears spread about a potential flu pandemic, Roche's antiviral drug Tamiflu (oseltamivir phosphate) has found ...

Innovations in drug formulations, such as pediatric-friendly suspensions and over-the-counter (OTC) availability, are further broadening the accessibility and appeal of Tamiflu. Key factors ...

BEIJING – The rapid spread of seasonal influenza in China in recent weeks has increased the demand for a certain antiviral ...

The proliferation of generic Tamiflu offerings, especially in cost-sensitive regions like Asia Pacific and Latin America, is boosting accessibility and driving adoption. Furthermore, strategic ...